Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Imprimis Pharmaceuticals Inc (NASDAQ:IMMY)

7.52
Delayed Data
As of Sep 04
 -0.06 / -0.79%
Today’s Change
6.72
Today|||52-Week Range
9.24
+0.27%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$72.7M

Company Description

Imprimis Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the commercial development of novel drug formulations and proprietary drug delivery vehicles. It focuses on meeting unmet patient needs through the development and commercialization of innovative proprietary sterile and topical drug formulations and technologies that are customized for patients. Its network of innovators includes inventive physicians and pharmacists. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in San Diego, CA.

Contact Information

Imprimis Pharmaceuticals, Inc.
12264 El Camino Real
San Diego California 92130
P:(858) 704-4040
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Mark L. BaumChief Executive Office & Director
Joe BittermanSenior Operations Director
Andrew R. BollChief Financial Officer & Secretary
John P. SaharekChief Commercial Officer
Gary W. SeelhorstVice President-Business Development